Dr. Brownell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 UCLA Medical Plz
Ste 630
Los Angeles, CA 90024Phone+1 310-825-9011Fax+1 310-206-9133
Summary
- Dr. Nicholas Brownell is a cardiology fellow (PGY-8) at UCLA. He received his medical degree from Emory University School of Medicine and completed his residency in internal medicine at UT Southwestern. He is currently a cardiology research fellow at UCLA David Geffen School of Medicine, where he is also completing a PhD in Health Policy and Management. He has been in practice for 8 years.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 2019 - 2024
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2015 - 2018
- Emory University School of MedicineClass of 2015
- University of PennsylvaniaB.S., Bioengineering, Cum Laude, 2006 - 2010
Certifications & Licensure
- CA State Medical License 2019 - 2025
- TX State Medical License 2017 - 2020
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Email Nudges to Improve GDMT (MRA) Adherence in Heart Failure Start of enrollment: 2023 Apr 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 14 citationsAssociation Between Peptidoglycan Recognition Protein-1 and Incident Atherosclerotic Cardiovascular Disease Events: The Dallas Heart Study.Nicholas Brownell, Amit Khera, James A. de Lemos, Colby Ayers, Anand Rohatgi
Journal of the American College of Cardiology. 2016-05-17 - 226 citationsDGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytesCharles A. Harris, Joel T. Haas, Ryan S. Streeper, S. Stone, Manju Kumari
Journal of Lipid Research. 2011-04-01 - 20 citationsThe Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection FractionNicholas K Brownell, Boback Ziaeian, Gregg C. Fonarow
Cardiac Failure Review. 2021-11-26
Authored Content
- Cardiac Arrest: When the Heart Stops, Save Lives with High-Quality CPRSeptember 2023
- Simultaneous Versus Sequential Initiation of HFrEF TherapiesMarch 2022
- VERTIS CV Trial: Heterogeneity in Clinical Benefits of Sodium-glucose Cotransporter-2 Inhibitors for Patients with Type II Diabetes?September 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: